We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

67 hedge funds and large institutions have $8.02M invested in T2 Biosystems, Inc in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more call options, than puts

Call options by funds: $191K | Put options by funds: $122K

4% less funds holding

Funds holding: 7067 (-3)

19% less capital invested

Capital invested by funds: $9.92M → $8.02M (-$1.89M)

38% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 13

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
67
Holders Change
-3
Holders Change %
-4.29%
% of All Funds
1.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
8
Reduced
13
Closed
5
Calls
$191K
Puts
$122K
Net Calls
+$69K
Net Calls Change
-$34K
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
76
JP Morgan Chase
New York
-$9K -4 Closed
GHAM
77
Gilman Hill Asset Management
Connecticut
-$6K -2 Closed
WT
78
Washington Trust
Rhode Island
-$1K

TTOO Hedge Fund Activity: Q1 2022 in Review

67 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2022, worth a combined $8.02M — down 19% from $9.92M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TTOO and 2 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 8 added.

The largest buyer was Franklin Resources, adding an estimated $115K. The largest seller was Vanguard Group, cutting an estimated $703K.

  • 67 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2022, down from 70 in Q4 2021.
  • Funds reported $8.02M of T2 Biosystems, Inc stock for Q1 2022, down 19% quarter-over-quarter.
  • 2 funds opened new T2 Biosystems, Inc positions in Q1 2022 and 5 closed out, a net change of -3 holders.
  • The largest T2 Biosystems, Inc buyer in Q1 2022 was Franklin Resources, an estimated $115K added.
  • The largest T2 Biosystems, Inc seller in Q1 2022 was Vanguard Group, an estimated $703K sold.

Based on aggregated 13F filings for Q1 2022.